Hold Lupin, Sun Pharma: Ambareesh Baliga

Ambareesh Baliga, Market Expert told CNBC-TV18, "We should remember that Lupin had fallen from that Rs 1,900 levels odd close to Rs 1,400 because of the US FDA issues and that is clearing up to a certain extent and we have seen that bounce back. However, I don’t see this stock really moving up immediately beyond Rs 1,800-1,825; that is where we could face some resistance.""However, as far as the pharmaceutical sector is concerned, this is one of those few stocks which I would possibly hold. Lupin and Sun Pharmaceutical Industries are the ones which I will hold possibly for longer term. However, in the short-term, a movement to about Rs 1,800-1,850, not beyond that," he added.